504905 Sigma-AldrichMemantine Hydrochloride - CAS 41100-52-1 - Calbiochem
Memantine Hydrochloride is a very potent, voltage-dependent, rapidly unbinding antagonist (calcium channel blocker) of NMDA receptors.
More>> Memantine Hydrochloride is a very potent, voltage-dependent, rapidly unbinding antagonist (calcium channel blocker) of NMDA receptors. Less<<Sinónimos: 3,5-Dimethyl-1-adamantanamine hydrochloride
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| CAS # | Empirical Formula |
|---|---|
| 41100-52-1 | C₁₂H₂₁N•HCl |
Precios y disponibilidad
| Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
|---|---|---|---|---|---|---|
| 5.04905.0001 |
|
Frasco de vidrio | 50 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 41100-52-1 |
| Form | White solid |
| Hill Formula | C₁₂H₂₁N•HCl |
| Chemical formula | C₁₂H₂₁N•HCl |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | NMDA receptors |
| Primary Target IC<sub>50</sub> | 0.8, 0.57, 0.52, and 0.54 →M for GluN2A, B, C, and D, respectively. |
| Purity | ≥98% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| 5.04905.0001 | 04055977263633 |
Documentation
Memantine Hydrochloride - CAS 41100-52-1 - Calbiochem Ficha datos de seguridad (MSDS)
| Título |
|---|
Referencias bibliográficas
| Visión general referencias |
|---|
| Limapichat, W., et al. 2012. ACS Chem. Neurosci. 4, 255. Anand, A., et al. 2012. Bipolar Dis. 14, 64. Lopes, P., et al. 2013. Brain and Behavior. 3, 67. Howard, R., et al. 2012. New Eng. J. Med. 366, 893. Parsons, G., et al. 1999. Neuropharmacol. 38, 735. Lee, G., et al. 2012. Psychiatry Investig. 9, 166. |



